Account
SH Kelkar appoints Publicis as its creative agency
MUMBAI: Fragrance and flavour provider, SH Kelkar & Company has awarded its creative duties to Publicis Worldwide. The business was awarded to Publicis following a multi-agency pitch.
The family owned business which started manufacturing fragrances in 1922 is a one of the leading fragrance and flavour makers in India. Apart from having strong roots in India, the company has successfully forayed into Europe, Middle East, South-East Asia and African markets with manufacturing units in India and Netherlands. SHK is credited with being the fragrance and flavour provider of many iconic brands, both International and domestic and across categories.
On winning the business, Publicis CEO South Asia, Nakul Chopra said, “We are extremely pleased to have an opportunity to partner a pedigreed company like SH Kelkar. Especially given that their business will provide exciting opportunities for holistic communication solutions. We look forward to working with them”
SH Kelkar & Co. CEO B. Ramkrishnan added, “We are a mid-sized company with global presence– and the largest fragrance house in India – with aggressive plans for the future. I am extremely happy that Publicis is partnering with us in our quest to firmly establish our identity in the global arena.”
“Fragrance is a business where science and art of the highest order come together, we have a creative resonance between our teams that will hopefully result in some great branding, design and communication. We are proud to partner a company with a heritage of almost 90 years in India and expanding to the world markets. We hope to play a significant role in SHK’s future growth plans”, concluded Publicis executive vice president Paritosh Srivastava.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
